To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Apax bets on generics with two European deals
The firm has acquired neuraxapharm in Germany and Invent Farma in Spain as it looks to consolidate the European generics market.
